Skip to content

King Pharmaceuticals KG International — Total IBNR

Other product segments

General Liability
4,098,200,000%
European Hospital Liability
1,391,000,000%
Commercial Auto Liability
715,500,000%
All other lines
551,000,000%

Similar metrics at other companies

CNA Financial logo
CNAInternational — IBNR
$1.91B
Hamilton Insurance Group, Ltd. logo
HGInternational - Property — IBNR
$82.47M+6.3%
Hamilton Insurance Group, Ltd. logo
HGInternational - Specialty — IBNR
$393.17M+27.2%
CNA Financial logo
CNAInternational — Net IBNR Reserves
$1.96B+17.1%
CNA Financial logo
CNAInternational — Gross IBNR Reserves
$2.32B+13.7%
Hamilton Insurance Group, Ltd. logo
HGInternational - Casualty — IBNR
$582.84M+28.8%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — total ibnr.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's international — total IBNR?
King Pharmaceuticals (KG) reported international — total IBNR of 313,500,000% in Q4 2025.
What does international — total IBNR mean?
This metric measures the total reserves held for Incurred But Not Reported (IBNR) claims within the international segment. It represents the estimated liability for losses that have occurred but have not yet been formally reported to the insurer. Accurate IBNR estimation is critical for maintaining solvency and ensuring that the company has sufficient capital to meet future obligations.